My NIH research was conducted at the University of Kansas, dept. of Medicinal Chemistry. We developed an effective semi-synthesis of the cancer drug Taxol (Paclitaxol) as well as a total synthesis of an anti-cancer agent known as Salilcylihalamide. I’m currently employed as an instructor at a small college.
Thank you for your contributions in fighting cancer. The funding by the NIH for cancer research is some of the very best money spent by the federal government and it apears to me that the programs they fund are based on merit.
Sir,
Have your colleagues discussed the best way to nominate specific programs to moonshot, without running through a political gauntlet or vetting by Big Pharma?